Most People With Cancer Respond Well To Covid-19 Vaccines, But Some Remain Vulnerable
A new study conducted in the U.S. and Switzerland has shown that the majority of people with cancer responded well to Covid-19 vaccines, creating protective antibodies after their second dose.
Due to treatments which can compromise the immune system, there are concerns that people with cancer might not be able to mount an immune response to Covid-19 vaccines. However, a new study published in Cancer Cell involving 131 people with cancer showed that 94% of them developed protective antibodies against the SARS-CoV2 coronavirus after being given either the Moderna or Pfizer mRNA vaccines.
But although the news is reassuring for most people with cancer, the amount of antibodies produced was lower in patients being treated with cytotoxic